The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 346:209-210 January 17, 2002 Number 3
NextNext

Prevention of Recurrent Variceal Bleeding

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Villanueva et al. (Aug. 30 issue)1 compared two treatments for recurrent bleeding from esophageal varices: endoscopic ligation and combined therapy with nadolol and isosorbide mononitrate. The initial dose of nadolol was 80 mg per day, and the mean (±SD) dose was 96±56 mg per day. In a review article in the same issue,2 Sharara and Rockey state that the initial dose of nadolol is 20 mg per day and the maximal dose is 80 mg per day. How many patients in the study by Villanueva et al. received doses of nadolol of more than 80 mg per . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.